For women facing the physical and psychological burdens of gynaecological cancer, the path toward healing often extends beyond traditional clinical interventions.
A hospital-based study published in Cureus suggests that for many patients, personal religiosity acts as a significant buffer against the heavy emotional toll of a cancer diagnosis, particularly when managing depressive symptoms.
The research, which tracked 50 women undergoing treatment for gynaecological malignancies between September 2024 and August 2025, highlights a complex interplay between faith and mental health. While medical advancements have drastically improved survival rates for cancers of the cervix, ovaries, and uterus, the psychological fallout—including anxiety, depression, and concerns regarding body image or fertility—remains a persistent barrier to overall quality of life.
In this study, researchers utilized the Hamilton Depression Rating Scale and the Hamilton Anxiety Rating Scale to assess the prevalence of distress. They found that 34% of participants met the criteria for depressive symptoms, while 40% struggled with anxiety. These figures highlight the high baseline of psychological strain within this patient population.
The data reveals that as religiosity scores increased, the negative impact of depression on a patient’s quality of life was significantly lessened. The study found that while anxiety and depression were both negatively correlated with overall well-being, religiosity served as a specific moderator for depressive symptoms, accounting for an 8.4 percentage point increase in the explained variance of quality of life outcomes.
“Higher religiosity was associated with lower psychological symptom scores and better health-related QOL among women with gynaecological malignancies.”
This finding is particularly relevant in the Indian sociocultural context, where community-based rituals and spiritual practice are often deeply woven into the fabric of daily life. For many patients, these practices provide more than just comfort; they offer a framework for coping that is inherently accessible during the isolating experience of cancer treatment.
The researchers observed a clear distinction in how religiosity interacts with different types of distress. While the moderating effect on depression was statistically significant, the study did not find a corresponding interaction between religiosity and anxiety. This suggests that while faith may help a patient process the weight of a diagnosis, it may not function as a blanket solution for all forms of psychiatric morbidity.
| Metric | Prevalence or Correlation |
|---|---|
| Participants with Depressive Symptoms | 17 (34%) |
| Participants with Anxiety Symptoms | 20 (40%) |
| Correlation: Religiosity vs. Depressive Symptoms | rₛ = -0.298 (p = 0.035) |
| Correlation: Religiosity vs. Anxiety Symptoms | rₛ = -0.395 (p = 0.005) |
The study’s authors emphasize that these results should not be interpreted as a replacement for clinical psychiatric care. Instead, they argue that oncology teams should consider individual religious beliefs and coping preferences as part of a holistic, patient-centered approach. By acknowledging these cultural resources, care providers may be better equipped to support patients who rely on their faith to face the existential challenges of their illness.
The global context for this research is stark. According to GLOBOCAN 2022 estimates, the world saw approximately 20 million new cancer cases, a significant rise from the 14.1 million reported in 2012. With the total cancer burden projected to grow by 77% by 2050, the need for culturally sensitive, accessible psychosocial support tools is becoming an urgent priority in public health strategy.
As the medical community continues to refine therapeutic interventions, this research serves as a reminder that the “total patient” includes their spiritual and social identity. Larger longitudinal studies are now required to determine how these findings might be translated into clinical practice across more diverse healthcare settings.